A meta-analysis assessed use of fluvoxamine, a drug used to treat depression, for preventing hospitalization among those with COVID-19 infection.
Investigators conducted a serial cross-sectional analysis to evaluate the use of modalities for pain management among individuals with chronic or postsurgical pain.
Faster rates of global cognitive decline, executive function decline observed for those with ultraprocessed food consumption above first quartile
However, those with persistent pain were no more likely to experience cognitive decline
More frequent surveillance not linked to longer recurrence-free, overall survival in pathologic stage I non-small cell lung cancer
SGLT-2is associated with lowest probability for adverse outcomes followed by glucagon-like peptide-1 receptor agonists, metformin
Researchers examined whether a higher (77 mmHg) or lower (63 mmHg) target mean arterial blood pressure would prevent death or severe anoxic brain injury in patients who are comatose after out-of-hospital cardiac arrest.
Researchers sought to determine whether preexisting diagnosis of or treatment for a neuropsychiatric condition is associated with severe COVID-19 infection and other SARIs and whether any observed association is similar between the 2 outcomes.
Researchers review the use of a recombinant humanized anti-interleukin-6 receptor monoclonal antibody in patients with glucocorticoid-resistant giant cell arteritis.
As people living with HIV begin to age, their risk of developing HIV-associated cognitive decline increases. A specific training program to help patients with HIV with speed of processing (SOP) may help stall those effects.